Benitec settles another lawsuit
Tuesday, 24 August, 2004
RNAi company Benitec (ASX: BLT) has settled its second patent infringement lawsuit in two weeks, giving US company Genscript Corporation a non-exclusive worldwide licence to manufacture and sell DNA-directed RNAi (ddRNAi) products.
The lawsuit was one of three filed on March 22, 2004 against US companies Ambion, Genscript and Nucleonics. Ambion was granted a licence as part of a settlement announced on August 10. Financial details of the settlement and licence were not disclosed.
The company has also been granted a second UK patent related to its ddRNAi technology for use of ddRNAi expressed as hairpins in vertebrate animal cells, bringing the number of issued patents in the company's portfolio to eight.
Giving rotavirus vaccine at birth benefits gut bacteria
Babies who receive a RV3-BB rotavirus vaccine at birth appear to show higher levels of good...
TGA approves donanemab for treatment of early Alzheimer's
The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...
Ultra-processed foods linked to poor health, premature death
Evidence suggests a dose-response relationship between ultra-processed food consumption and...
